Meds A-Z
Fenbendazole
Detailed information about Fenbendazole
Pet Owner Quick Guide
Start here: what this medicine is for, what it does, and when it's usually needed.
Usually used for:
For the treatment and control of: Lungworms : Adult Dictyocaulus viviparu s; Stomach worms : Adult brown stomach worms ( Ostertagia ostertagi ), Adult and fourth stage larvae barberpole worms ( Haemonchus contortus & H.
What it does:
For the treatment and control of large strongyles ( Strongylus edentatus , S. equinus , S. vulgaris , Triodontophorus spp.),small strongyles ( Cyathostomum spp., Cylicocyclus spp., Cylicostephanus spp., Cylicodontophorus...
When it's needed:
Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not necessary. Retreat in 6 to 8 weeks if required. Do not use in hor...
Call your vet sooner if you notice:
- Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not necessary. Retreat in 6 to 8 weeks if required. Do not use in horses intended for food. Consult your veterinarian assistance in the diagnosis, treatment, and control of parasitism. Do not use in horses intended for human consumption. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism. Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed.
Commonly reported reactions:
- (2 reports)
- (1 reports)
- (1 reports)
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Fenbendazole
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: Intervet, Inc.
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200831 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/141144 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not necessary. Retreat in 6 to 8 weeks if required. Do not use in horses intended for food. Consult your veterinarian assistance in the diagnosis, treatment, and control of parasitism. Do not use in horses intended for human consumption. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism. Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed.
- High: Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not necessary. Retreat in 6 to 8 weeks if required. Do not use in horses intended for food. Consult your veterinarian assistance in the diagnosis, treatment, and control of parasitism. Do not use in horses intended for human consumption. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism. Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed.
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Most Reported Reactions
| Reaction | Cases | Species | Serious cases |
|---|---|---|---|
| 2 | Cat, Dog | 1 | |
| 1 | Cat | 1 | |
| 1 | Cat | 1 | |
| 1 | Cat | 1 | |
| 1 | Cat | 1 | |
| 1 | Cat | 1 | |
| 1 | Cat | 1 | |
| 1 | Cat | 1 |
Species coverage: Cat (26) Dog (6)
View detailed reaction table
| Reaction | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Dog | Unknown | - | - | |
| Dog | Unknown | - | - | |
| Dog | Unknown | - | - |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2025-US-045743
Storage & Handling
No storage/handling guidance is linked yet.
Documents
Official label facts are separated from secondary summaries.
Official documents: 57 • Secondary summaries: 0
- FOI Summary oA 200-831 Approved January 13, 2026.pdf · FOI
- Defendazole™ · SPL
- ucm117184.pdf · FOI
- BMD® / Safe-Guard® · SPL
- FOI Summary sN 131-675 Approved May 23, 2024.pdf · FOI
- FOI Summary sN 131-675 Approved January 10, 2022.pdf · FOI
- UCM364715.pdf · FOI
- ucm069865.pdf · FOI
- ucm069862.pdf · FOI
- ucm069858.pdf · FOI
- N131675_Supp_03_30_1991.pdf · FOI
- UCM470924.pdf · FOI
- 131-675 · EA
- 131-675 · FONSI
- 131-675 · EA
- 131-675 · FONSI
- Safe-Guard® · SPL
- FOI Summary sN 132-872 Approved March 24, 2021.pdf · FOI
- N-132872-Q-0140-OT-AA_foi.pdf · FOI
- 132-872 · EA
- 132-872 · FONSI
- Safe-Guard® · SPL
- UCM478252.pdf · FOI
- SAFE-GUARD® plus LINCOMIX® · SPL
- FOI Summary sN 128-620 Approved June 14, 2021.pdf · FOI
- ucm069824.pdf · FOI
- ucm069823.pdf · FOI
- N-128620-Q-0179-OT-AA_foi.pdf · FOI
- N128620_Supp_04_25_1994.pdf · FOI
- 128-620 · EA
- 128-620 · FONSI
- Safe-Guard® · SPL
- Panacur® · SPL
- Panacur® Suspension 10% · SPL
- N120648_Supp_May_28_1985.pdf · FOI
- safe-guard® · SPL
- panacur® · SPL
- ucm069818.pdf · FOI
- N121473_Suppl_5_31_1994.pdf · FOI
- Panacur® C (OTC) · SPL
- Safe-Guard® Canine (OTC) · SPL
- Panacur® Granules 22.2% (Rx) · SPL
- FOI Summary sN 139-189 Approved April 26, 2021.pdf · FOI
- UCM472706.pdf · FOI
- Safe-Guard® · SPL
- FOI Summary sN 141-449 Approved January 5, 2018.pdf · FOI
- UCM488824.pdf · FOI
- UCM471258.pdf · FOI
- 141-449 · EA
- 141-449 · FONSI
- 141-449 · EA
- 141-449 · FONSI
- 141-449 · EA
- 141-449 · FONSI
- Safe-Guard® AquaSol · SPL
- Purina® Worm-A-Rest Litter Pack · SPL
- Panacur® Granules 22.2% · SPL
No source yet.
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17870 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/18246/Defendazole%E2%84%A2 · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/659 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/505/BMD%C2%AE%20/%20Safe-Guard%C2%AE · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/15493 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/11816 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/402 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/401 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/400 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/399 · document · FOI
Promotional Materials (Marketing)
This content is marketing material and not clinical guidance.
No marketing assets are linked yet.
No source yet.
Technical appendix (vet reference)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
- Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Feb 16, 2026, 11:02 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:20 AM UTC
Diagnosis-code mappings are not available for this medication yet.
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
- Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not necessary. Retreat in 6 to 8 weeks if required. Do not use in horses intended for food. Consult your veterinarian assistance in the diagnosis, treatment, and control of parasitism. Do not use in horses intended for human consumption. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism. Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed. (Contraindication, High)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 0061-1433-01 | 0061 | - | |
| 0061-1433-02 | 0061 | - | |
| 0061-1433-03 | 0061 | - | |
| 43457-650-25 | 43457 | - | |
| 49452-3035-1 | 49452 | - | |
| 49452-3035-2 | 49452 | - | |
| 49452-3035-3 | 49452 | - | |
| 49452-3035-4 | 49452 | - | |
| 49452-3035-5 | 49452 | - | |
| 49452-3035-6 | 49452 | - | |
| 55529-165-06 | 55529 | - | |
| 55529-165-08 | 55529 | - | |
| 57926-081-44 | 57926 | - | |
| 57926-081-48 | 57926 | - | |
| 57926-083-44 | 57926 | - | |
| 57926-084-46 | 57926 | - | |
| 57926-085-47 | 57926 | - | |
| 57926-086-01 | 57926 | - | |
| 57926-087-01 | 57926 | - | |
| 57926-088-01 | 57926 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
FOI Summary oA 200-831 Approved January 13, 2026.pdf
• FOI summary • Official
• Feb. 2, 2026
FDA FOI summary for application 200831
-
ucm117184.pdf
• FOI summary • Official
• Nov. 12, 2024
FDA FOI summary for application 141144
-
UCM470924.pdf
• FOI summary • Official
• June 3, 2024
FDA FOI summary for application 131675
-
N131675_Supp_03_30_1991.pdf
• FOI summary • Official
• June 3, 2024
FDA FOI summary for application 131675
-
ucm069858.pdf
• FOI summary • Official
• June 3, 2024
FDA FOI summary for application 131675
-
ucm069862.pdf
• FOI summary • Official
• June 3, 2024
FDA FOI summary for application 131675
-
ucm069865.pdf
• FOI summary • Official
• June 3, 2024
FDA FOI summary for application 131675
-
UCM364715.pdf
• FOI summary • Official
• June 3, 2024
FDA FOI summary for application 131675
-
FOI Summary sN 131-675 Approved January 10, 2022.pdf
• FOI summary • Official
• June 3, 2024
FDA FOI summary for application 131675
-
FOI Summary sN 131-675 Approved May 23, 2024.pdf
• FOI summary • Official
• June 3, 2024
FDA FOI summary for application 131675
-
N-132872-Q-0140-OT-AA_foi.pdf
• FOI summary • Official
• Oct. 12, 2023
FDA FOI summary for application 132872
-
FOI Summary sN 132-872 Approved March 24, 2021.pdf
• FOI summary • Official
• Oct. 12, 2023
FDA FOI summary for application 132872
-
UCM478252.pdf
• FOI summary • Official
• Aug. 25, 2023
FDA FOI summary for application 140954
-
N128620_Supp_04_25_1994.pdf
• FOI summary • Official
• June 6, 2022
FDA FOI summary for application 128620
-
N-128620-Q-0179-OT-AA_foi.pdf
• FOI summary • Official
• June 6, 2022
FDA FOI summary for application 128620
-
ucm069823.pdf
• FOI summary • Official
• June 6, 2022
FDA FOI summary for application 128620
-
ucm069824.pdf
• FOI summary • Official
• June 6, 2022
FDA FOI summary for application 128620
-
FOI Summary sN 128-620 Approved June 14, 2021.pdf
• FOI summary • Official
• June 6, 2022
FDA FOI summary for application 128620
-
N120648_Supp_May_28_1985.pdf
• FOI summary • Official
• Jan. 25, 2022
FDA FOI summary for application 120648
-
N121473_Suppl_5_31_1994.pdf
• FOI summary • Official
• May 6, 2021
FDA FOI summary for application 121473
-
ucm069818.pdf
• FOI summary • Official
• May 6, 2021
FDA FOI summary for application 121473
-
UCM472706.pdf
• FOI summary • Official
• May 3, 2021
FDA FOI summary for application 139189
-
FOI Summary sN 139-189 Approved April 26, 2021.pdf
• FOI summary • Official
• May 3, 2021
FDA FOI summary for application 139189
-
UCM471258.pdf
• FOI summary • Official
• April 12, 2021
FDA FOI summary for application 141449
-
UCM488824.pdf
• FOI summary • Official
• April 12, 2021
FDA FOI summary for application 141449
-
FOI Summary sN 141-449 Approved January 5, 2018.pdf
• FOI summary • Official
• April 12, 2021
FDA FOI summary for application 141449
Data Sources & Revision History
Every non-trivial field is expected to include provenance and update timestamps.
- contraindications: Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not nece… (Official, 2026-02-12)
- side_effects: Top reported reactions (openFDA): Lack of efficacy (endoparasite) - hookworm, Vomiting, INEFFECTIVE, HOOKS, Diarrhoea, Other abnormal test result NOS, Lack of … (Official, 2026-02-12)
- usage: For the treatment and control of large strongyles ( Strongylus edentatus , S. equinus , S. vulgaris , Triodontophorus spp.),small strongyles ( Cyathostomum spp… (Official, 2026-02-12)
- side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
Defendazole™
OTC
Fenbendazole
Oral Suspension
• Oral
|
Norbrook Laboratories, Ltd. | ANADA 200-831 | Approved | Feb 2, 2026 |
|
BMD® / Safe-Guard®
OTC
Bacitracin methylenedisalicylate Fenbendazole
Medicated Feed
• Oral
|
Phibro Animal Health Corp. | NADA 141-144 | Approved | Nov 12, 2024 |
|
Safe-Guard®
OTC
Fenbendazole
Type A Medicated Article
• Oral
|
Intervet, Inc. | NADA 131-675 | Approved | Jun 3, 2024 |
|
Safe-Guard®
OTC
Fenbendazole
Paste
• Oral
|
Intervet, Inc. | NADA 132-872 | Approved | Oct 12, 2023 |
|
SAFE-GUARD® plus LINCOMIX®
VFD
Fenbendazole Lincomycin
Type A Medicated Article
• Oral
|
Intervet, Inc. | NADA 140-954 | W | Aug 25, 2023 |
|
Safe-Guard® Panacur®
OTC
Fenbendazole
Liquid (Suspension)
• Oral
|
Intervet, Inc. | NADA 128-620 | Approved | Jun 6, 2022 |
|
Panacur® Suspension 10%
RX
Fenbendazole
Liquid (Suspension)
• Oral
|
Intervet, Inc. | NADA 104-494 | Approved | Jun 2, 2022 |
|
safe-guard® panacur®
OTC
Fenbendazole
Paste
• Oral
|
Intervet, Inc. | NADA 120-648 | Approved | Jan 25, 2022 |
|
Panacur® C (OTC) Safe-Guard® Canine (OTC) Panacur® Granules 22.2% (Rx)
OTC
Fenbendazole
Top Dressing In Feed
• Oral
|
Intervet, Inc. | NADA 121-473 | Approved | May 6, 2021 |
|
Safe-Guard®
OTC
Fenbendazole
Medicated Feed Block
• Oral
|
Intervet, Inc. | NADA 139-189 | Approved | May 3, 2021 |
|
Safe-Guard® AquaSol
OTC
Fenbendazole
Oral Suspension
• Oral
|
Intervet, Inc. | NADA 141-449 | Approved | Apr 12, 2021 |
|
Purina® Worm-A-Rest Litter Pack
OTC
Fenbendazole
Medicated Feed
• Oral
|
Virbac AH, Inc. | NADA 136-116 | W | Nov 2, 2018 |
|
Panacur® Granules 22.2%
OTC
Fenbendazole
Top Dressing In Feed
• Oral
|
Intervet, Inc. | NADA 111-278 | Approved | Jun 1, 2016 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
For the treatment and control of:
Lungworms: Adult Dictyocaulus viviparus;
Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus & H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei);
Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).
2.3 mg/lb (5 mg/kg) body weight
For the treatment and control of:
Stomach worms (adults): Haemonchus contortus and Teladorsagia circumcincta.
2.3 mg/lb (5 mg/kg) body weight
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Fenbendazole: Type A medicated article in concentrations of 40, 80, and 200 grams fenbendazole activity per kilogram.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment and control of: Lungworms (Protostrongylus spp.).
10 mg fenbendazole/kg body weight/day x 3 days of treatment
For the treatment and control of: kidney worms (Stephanurus dentatus), roundworms (Ascaris suum), and nodular worms (Oesophagostomum dentatum).
3 mg fenbendazole/kg body weight/day x 3 days of treatment
For the treatment and control of: Stomach worms: small stomach worms (Trichostrongylus spp.), barberpole worms (Haemonchus spp.); Intestinal worms: thread-necked intestinal worms (Nematodirus spp.) and whipworms (Trichuris spp.)
2.5 mg fenbendazole/kg body weight/day x 3 days of treatment
For the treatment and control of: Gastrointestinal worms: Roundworms, Adults and larvae (Ascaridia dissimilis); Cecal worms, Adults and larvae (Heterakis gallinarum), an important vector of Histomonas meleagridis (Blackhead).
14.5 g fenbendazole/ton of feed, to be fed as the sole ration for 6 days
For the treatment and control of: Lungworms: Adult Metastrongylus apri, adult Metastrongylus pudendotectus; Gastrointestinal worms: Adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large roundworms (Ascaris suum), Adult nodular worms (Oesophagostomum dentatum, O. quadrispinulatum), Adult small stomach worms (Hyostrongylus rubidus), Adult and larvae (L2, L3, L4 stages- intestinal mucosal forms) whipworms (Trichuris suis); and Kidney worms: Adult and larvae Stephanurus dentatus.
9 mg fenbendazole per kg body weight (4.08 mg fenbendazole per pound) to be fed as the sole ration over a period of 3 to 12 days.
For the treatment and control of: Lungworms: Adult Dictyocaulus viviparus; Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus), fourth stage larvae barberpole worms (H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei); Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum)
5 mg fenbendazole per kg body weight in a one (1) day treatment (2.27 mg fenbendazole per pound). Feed as the sole ration for one (1) day. Free-Choice Feeds: Type C free-choice medicated feed must be manufactured by a licensed feed mill according to an approved formula to provide a total of 5 mg per kg body weight fenbendazole over 3 to 6 days.
For the treatment and control of: Large strongyles (Strongylus edentatus, S. equinus, S. vulgaris, Triodontophorus spp.), Small strongyles (Cyathostomum spp., Cylicocyclus spp., Cylicostephanus spp.), Pinworms (Oxyuris equi), and Ascarids (Parascaris equorum).
For the control of large strongyles, small strongyles, and pinworms the recommended dose is 5 mg fenbendazole per kg body weight (2.27 mg fenbendazole per pound) in a one (1) day treatment. For the control of ascarids the recommended dose is 10 mg fenbendazole per kg body weight (4.54 mg fenbendazole per pound) in a one (1) day treatment.
For the treatment and control of Gastrointestinal worms: Cecal worms, (Aulonocephalus spp.).
90.7 g of fenbendazole/ton of Type C medicated feed, to be fed for 21 consecutive days.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment and control of: Lungworms: Adult Dictyocaulus viviparus; Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus), fourth stage larvae barberpole worms (H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei); Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).
Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance. Consult a veterinarian for assistance in the diagnosis, treatment, and control of parasitism.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the removal of: Lungworms: Metastrongylus apri, metastrongylus pudendotectus; Gastrointestinal worms: adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large round worm (Ascaris suum); nodular worms (Oesophagostomum dentatum, O. quadrispinulatum); small stomach worm (Hyostrongylus rubidus); Kidney worm: adult and larvae Stephanurus dentatus. For treatment of swine dysentery.
10 to 80 grams fenbendazole and 100 grams lincomycin per ton Type C medicated feed
Calculate the amount of THIS feed that the pigs to be treated should eat within 3 to 12 days to get a total dose of 9 mg of fenbendazole per kilogram body weight (4.08 mg fenbendazole per pound body weight). Feed as the sole feed the calculated amount. When it is fully consumed resume normal feeding. Do not slaughter swine for human consumption for 6 days following last treatment with lincomycin. Occasionally, swine fed lincomycin may, within the first 2 days after the onset of treatment, develop diarrhea and/or swelling of the anus. On rare occasions, some pigs may show reddening of the skin and irritable behavior. These conditions have been self-correcting within 5- 8 days without discontinuing the lincomycin treatment. Do not allow rabbits, hamsters, guinea pigs, horses or ruminants access to feeds containing lincomycin. Ingestion by these species may result in severe gastrointestinal effects. The effects of lincomycin on swine reproductive performance, pregnancy, and lactation have not been determined. Feeds containing lincomycin are not to be fed to swine that weigh more than 250 lb.
For the removal of: Lungworms: Metastrongylus apri, metastrongylus pudendotectus; Gastrointestinal worms: adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large round worm (Ascaris suum); nodular worms (Oesophagostomum dentatum, O. quadrispinulatum); small stomach worm (Hyostrongylus rubidus); Kidney worm: adult and larvae Stephanurus dentatus. For the control of swine dysentery; for use in swine on premises with a history of swine dysentery, but where symptoms have not yet occurred.
10 to 80 grams fenbendazole and 40 grams lincomycin per ton Type C medicated feed.
Calculate the amount of THIS feed that the pigs to be treated should eat within 3 to 12 days to get a total dose of 9 mg of fenbendazole per kilogram body weight (4.08 mg fenbendazole per pound body weight). Feed as the sole feed thecalculated amount. When it is fully consumed resume normal feeding. Occasionally, swine fed lincomycin may, within the first 2 days after the onset of treatment, develop diarrhea and/or swelling of the anus. On rare occasions, some pigs may show reddening of the skin and irritable behavior. These conditions have been self-correcting within 5- 8 days without discontinuing the lincomycin treatment. Do not allow rabbits, hamsters, guinea pigs, horses or ruminants access to feeds containing lincomycin. Ingestion by these species may result in severe gastrointestinal effects. The effects of lincomycin on swine reproductive performance, pregnancy, and lactation have not been determined. Feeds containing lincomycin are not to be fed to swine that weigh more than 250 lb.
For the removal of: Lungworms: Metastrongylus apri, metastrongylus pudendotectus; Gastrointestinal worms: adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large round worm (Ascaris suum); nodular worms (Oesophagostomum dentatum, O. quadrispinulatum); small stomach worm (Hyostrongylus rubidus); Kidney worm: adult and larvae Stephanurus dentatus. For reduction in the severity of swine mycoplasma pneumonia caused by Mycoplasma hyopneumoniae.
10 to 80 grams fenbendazole and 200 grams lincomycin per ton Type C medicated feed.
Calculate the amount of THIS feed that the pigs to be treated should eat within 3 to 12 days to get a total dose of 9 mg of fenbendazole per kilogram body weight (4.08 mg fenbendazole per pound body weight). Feed as the sole feed the calculated amount. When it is fully consumed resume normal feeding. Do not slaughter swine for human consumption for 6 days following last treatment with lincomycin. Occasionally, swine fed lincomycin may, within the first 2 days after the onset of treatment, develop diarrhea and/or swelling of the anus. On rare occasions, some pigs may show reddening of the skin and irritable behavior. These conditions have been self-correcting within 5- 8 days without discontinuing the lincomycin treatment. Do not allow rabbits, hamsters, guinea pigs, horses or ruminants access to feeds containing lincomycin. Ingestion by these species may result in severe gastrointestinal effects. The effects of lincomycin on swine reproductive performance, pregnancy, and lactation have not been determined. Feeds containing lincomycin are not to be fed to swine that weigh more than 250 lb.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment and control of: Lungworms: Adult Dictyocaulus viviparus; Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus & H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei); Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).
Administer orally at a dose of 2.3 mg/lb (5 mg/kg) body weight.
For the treatment and control of: Stomach worms (adults): Haemonchus contortus and Teladorsagia circumcincta.
Administer orally at a dose of 2.3 mg/lb (5 mg/kg) body weight.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment and control of large strongyles (Strongylus edentatus, S. equinus, S. vulgaris, Triodontophorus spp.),small strongyles (Cyathostomum spp., Cylicocyclus spp.,Cylicostephanus spp., Cylicodontophorus spp.), and pinworms (Oxyuris equi).
Administer orally at a dose of 2.3 mg/lb (5 mg/kg).
For the treatment and control of ascarids (Parascaris equorum).
Administer orally at a dose of 4.6 mg/lb (10 mg/kg).
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment and control of large strongyles (Strongylus edentatus, S. equinus, S. vulgaris), encysted early 3rd stage (hypobiotic), late 3rd stage and 4th stage cyathostome larvae, small strongyles, pinworms (Oxyuris equi), ascarids (Parascaris equorum), and for the control of arteritis caused by 4th stage larvae of Strongylus vulgaris in horses.
For large strongyles, small strongyles, and pinworms, the recommended dose is 5 mg/kg (2.3 mb/lb) administered once orally. For ascarids, the recommended dose is 10 mg/kg (4.6 mg/lb) administered once orally. For treatment and control of hypobiotic (encysted early 3rd stage), late 3rd stage, and 4th stage cyathostome larvae, as well as 4th stage Strongylus vulgaris larvae, the recommended dose is 10 mg/kg (4.6 mg/lb) administered orally daily for 5 consecutive days.
Do not use in horses intended for human consumption. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment and control of: Lungworms: Adult Dictyocaulus viviparus; Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus), fourth stage larvae barberpole worms (H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei); Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).
Feed free-choice at a rate of 0.1 pound of block per 100 lb body weight (BW) per day for 3 days to deliver a total of 2.27 mg fenbendazole/lb BW (5 mg/kg BW). Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance. Consult a veterinarian for assistance in the diagnosis, treatment, and control of parasitism.
Administer free choice of beef cattle on pasture that have become accustomed to non-medicated block feeding during an adaptation period of 12 to 19 days. Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment and control of: Lungworms: Adult Metastrongylus apri, adult Metastrongylus pudendotectus; Gastrointestinal worms: Adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large roundworms (Ascaris suum), Adult nodular worms (Oesophagostomum dentatum, O. quadrispinulatum), Adult small stomach worms (Hyostrongylus rubidus), Adult and larvae (L2, L3, L4 stages- intestinal mucosal forms) whipworms (Trichuris suis); and Kidney worms: Adult and larvae Stephanurus dentatus.
For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens and for the treatment and control of adult A. galli and Heterakis gallinarum in breeding chickens and laying hens.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
-
Summary
For the treatment and control of:
Lungworms: Adult Dictyocaulus viviparus;
Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus & H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei);
Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).
Goats- 2.3 mg/lb (5 mg/kg) body weight for the treatment and control of: Stomach worms (adults): Haemonchus contortus and Teladorsagia circumcincta.
- Defendazole™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm117184.pdf
Summary
Fenbendazole is indicated for the removal of:
Lungworms: adult (Metastrongylus apri, M. pudendotectus)
Gastrointestinal worms: adult and larvae (L3, L4 stages – liver, lung, and intestinal forms) large roundworms (Ascaris suum), adult nodular worms (Oesophagostomum dentatum, O. quadrispinulatum), small stomach worms (Hyostrongylus rubidus), adult and larvae (L2, L3, L4 stages – intestinal mucosal forms) whipworms (Trichuris suis);
Kidneyworms: adult and larvae (Stephanurus dentatus) Bacitracin methylene disalicylate is indicated for:
Increased rate of weight gain and improved feed efficiency in growing and finishing swine;
Control of clostridial enteritis in suckling pigs caused by Clostridium perfringens when fed to pregnant sows during the period from 14 days before farrowing through 21 days after farrowing;
Control of swine dysentery associated with Treponema hyodysenteriae in growing and finishing swine on premises with a history of swine dysentery but where signs of disease have not yet occurred or following an approved treatment of the disease
- BMD® / Safe-Guard® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
This supplement provides for addition of wild quail with the indication for the treatment and control of Aulonocephalus spp. in wild quail.
-
Summary
This supplement provides for 1) tolerances and tissue withdrawal periods in cattle, swine, and turkeys, and a milk discard time in cattle in accordance with a repartitioning of the acceptable daily intake (ADI); and 2) the addition of fourth stage larval indications for barberpole worms (Haemonchus contortus & H. placei), small stomach worms (Trichostrongylus axei), hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum) in cattle.
-
FOI UCM364715.pdf
Summary
This supplement provides for the Type A medicated article to be used to manufacture a free-choice liquid Type C medicated feed for use in dairy and beef cattle. -
FOI ucm069865.pdf
Summary
This supplement to NADA 131-675 provides for a new claim for control of gastrointestinal worms in horses [large strongyles (Strongylus edentatus, S. equinus, S. vulgaris, Triodontophorus spp.), small strongyles (Cyathostomum spp., Cylicocyclus spp., Cylicostephanus spp.), pinworms (Oxyuris equi), and ascarids (Parascaris equorum)]. -
FOI ucm069862.pdf
Summary
This supplement provides for the addition of growing turkeys to the previously approved SAFE-GUARD® Type A medicated article labeling. -
FOI ucm069858.pdf
Summary
This supplement provides for the revision 21 CFR 556.275 by establishing tolerances for residues in swine liver and muscle and adding allowable daily intake (ADI). -
Summary
This supplement provides for an additional Type A medicated article (premix) containing 8% fenbendazole for the same indications for use in Type C medicated swine feed as the currently approved Type A medicated articles containing 4% and 20% fenbendazole. See 21 CFR 558.258.
-
FOI UCM470924.pdf
Summary
This supplemental approval provides for the minor use -
EA 131-675
-
FONSI 131-675
-
EA 131-675
-
FONSI 131-675
- Safe-Guard® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
This supplement provides for 1) tolerances, a tissue withdrawal period, and a milk discard time in accordance with a repartitioning of the ADI; and 2) the addition of fourth stage larval indications for barberpole worms (Haemonchus contortus and H. placei), small stomach worms (Trichostrongylus axei), hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).
-
Summary
This supplement provides for the use of fenbendazole for the removal and control of gastrointestinal parasites and lungworm in dairy cattle of breeding age. -
EA 132-872
-
FONSI 132-872
- Safe-Guard® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM478252.pdf
Summary
Fenbendazole is indicated for the removal of: LUNGWORMS; GASTROINTESTINAL WORMS; KIDNEYWORMS ..1. increased rate of weight gain in growing-finishing swine 2. for control of swine dysentery; for use in swine on premises with a history of swine dysentery, but where symptoms have not yet occurred 3. for treatment swine dysentery 4. for reduction in the severity of swine mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae.
FDA page: Open in Animal Drugs @ FDA
-
Summary
This supplement provides for tolerances, a tissue withdrawal period, and a milk discard time in cattle; and a tolerance and tissue withdrawal period in goats in accordance with a repartitioning of the acceptable daily intake (ADI).
-
FOI ucm069824.pdf
Summary
1) The marketing status of fenbendazole suspension for use in goats is changed from prescription (Rx) to over-the-counter (OTC) by removing goats from the Panacur® Suspension 10% label and by adding goats to the Safe-GuardR Suspension 10% label. The formulation of the two products is identical. 2) The indications for use in goats are revised from "for the removal and control of stomach and intestinal worms Haemonchus contortus and Ostertagia circumcincta" to "for the removal and control of stomach worms (adults) Haemonchus contortus and Teladorsagia circumcincta.¨
-
FOI ucm069823.pdf
Summary
This supplement provides for establishing tolerances for residues of parent fenbendazole in muscle of cattle and goats. -
Summary
...effectively removes and controls infections in cattle due to Dictyocaulus viviparus, stomach worms, and intestinal worms
-
Summary
This supplement provides for an expanded use of fenbendazole in a new species (goats).
-
EA 128-620
-
FONSI 128-620
- Safe-Guard® (ZIP)
- Panacur® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Panacur® Suspension 10% (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For treatment of encysted mucosal cyathostome (small strongyle) larvae including hypobiotic early third stage, late third stage and fourth stage larvae at 10 mg/kg/day for 5 consecutive days.
- safe-guard® (ZIP)
- panacur® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm069818.pdf
Summary
This supplement provides for a change from prescription (Rx) to OTC status for fenbendazole granules 22.2% packets to be marketed under the trade name PANACUR®-C. The jar presentation (Panacur®) will remain prescription (Rx) as it is also labeled for use in other species of carnivorous/omnivorous animals. The jar presentation will continue to be marketed under the Panacur® trade name. -
Summary
This supplement provides a claim as an anthelmintic in the following species within the families Felidae and Ursidae: lion (Panthera leo), tiger (Panthera tigris) cheetah (Acinonyx jubatus) Puma (Felis concolor), Jaguars (Panthera onca), Leopard (Panthera pardus), Panther (Panthera spp), Grizzly Bear (Ursus horribilis), Polar Bear (Ursus maritimus), and Black Bear (Ursus americanus).
- Panacur® C (OTC) (ZIP)
- Safe-Guard® Canine (OTC) (ZIP)
- Panacur® Granules 22.2% (Rx) (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
This supplement provides for 1) a tolerance and tissue withdrawal periods in accordance with a repartitioning of the ADI; and 2) the addition of fourth stage larval indications for barberpole worms (Haemonchus contortus and H. placei), small stomach worms (Trichostrongylus axei), hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).
-
FOI UCM472706.pdf
Summary
The original approval provided for a 25 lb. medicated molasses block containing 750 milligrams of fenbendazole per pound as a beef cattle anthelmintic. The molasses block requires an 11-day withdrawal. This supplemental approval provides for a 33-1/2 pound cold press medicated 20% protein feedblock containing 750 milligrams of fenbendazole per pound as a beef cattle anthelmintic. The cold press 20% protein block requires a 16-day withdrawal period.
- Safe-Guard® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
This supplement provides for the following: 1) the addition of "and laying hens" to the indication for treatment and control of adult A. galli and H. gallinarum; 2) the removal of the limitation of "intended to become breeding chickens" from "replacement chickens" in the treatment and control portion of the A. galli only part of the indication; and 3) the removal of the limitation, "Not for use in laying hens and replacement chickens intended to become laying hens" in the indication.
-
FOI UCM488824.pdf
Summary
This supplement provides for the addition of swine, except for nursing piglets, for the following indications: For the treatment and control of Lungworms: Adult Metastrongylus apri, adult Metastrongylus pudendotectus; Gastrointestinal worms: Adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large roundworms ( Ascaris suum); nodular worms ( Oesophagostomum dentatum, O. quadrispinulatum); small stomach worms ( Hyostrongylus rubidus); Adult and larvae (L2, L3, L4 stages – intestinal mucosal forms) whipworms ( Trichuris suis); and Kidney worms: Adult and larvae Stephanurus dentatus. -
FOI UCM471258.pdf
Summary
For the treatment and control of adult Ascaridia galli in broiler chickens and replacement chickens intended to become breeding chickens and for the treatment and control of adult A. galli and Heterakis gallinarum in breeding chickens. -
EA 141-449
-
FONSI 141-449
-
EA 141-449
-
FONSI 141-449
-
EA 141-449
-
FONSI 141-449
- Safe-Guard® AquaSol (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- Panacur® Granules 22.2% (ZIP)
FDA page: Open in Animal Drugs @ FDA
Usage
For the treatment and control of large strongyles ( Strongylus edentatus , S. equinus , S. vulgaris , Triodontophorus spp.),small strongyles ( Cyathostomum spp., Cylicocyclus spp., Cylicostephanus spp., Cylicodontophorus spp.), and pinworms ( Oxyuris equi ). For the treatment and control of ascarids ( Parascaris equorum ). For the control of infections of large strongyles (Strongylus edentatus, S. equinus, S. vulgaris), small strongyles, pinworms (Oxyuris equi), and ascarids (Parascaris equorum).
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
Sprinkle the appropriate amount of drug on a small amount of the usual grain ration. Prepare for each horse individually. Withholding feed or water is not necessary. Retreat in 6 to 8 weeks if required. Do not use in horses intended for food. Consult your veterinarian assistance in the diagnosis, treatment, and control of parasitism. Do not use in horses intended for human consumption. Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism. Mix the appropriate amount of drug with a small amount of the usual food. Dry dog food may require slight moistening to facilitate mixing. Medicated food must be fully consumed.
Side Effects
No approved side-effect narrative is linked yet.
openFDA reaction signals are available for Dog 56 and Cat 20 (view top reported reactions).
Top Reported Reactions (openFDA)
Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, Crossbred Canine/dog, Unknown, 6 month, 15.88 kilogram • Drug: MSK, Unknown, Dose: 50 Milligram per kilogram, Frequency: 1 per day • Reactions: Lack of efficacy - NOS, Lack of efficacy (endoparasite) - hookworm • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-055986
- Serious AE: No
- Treated For AE: Yes
- Sex: Unknown
- Age: 6.00 Month
- Weight: 15.880 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Dose: 50 Milligram per kilogram
- Frequency: 1 per day
Dog, Retriever - Labrador, Female, 1 year, 21.818 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Lack of efficacy (endoparasite) - hookworm • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055119
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 1.00 Year
- Weight: 21.818 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Unassigned
Cat, Domestic Shorthair, Male, 7 week, 0.363 kilogram • Drug: MSK, Oral, Dose: 1 Other per animal • Reactions: Death • Outcome: Died
- Report ID: USA-USFDACVM-2025-US-052904
- Serious AE: Yes
- Treated For AE: No
- Sex: Male
- Age: 7.00 Week
- Weight: 0.363 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Dose: 1 Other per animal
Dog, Dog (unknown), Female, 15.87 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy (endoparasite) - hookworm • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-054252
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Weight: 15.870 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Dog, Dog (unknown), Female, 30.85 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy (endoparasite) - heartworm • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-054376
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Weight: 30.850 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Dog, Dog (unknown), Female, 20.412 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy (endoparasite) - hookworm • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-052827
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Weight: 20.412 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Cat, Domestic Shorthair, Male, 3.58 year, 4.3 kilogram • Drug: MSK, Unknown • Reactions: Vomiting • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-052893
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 3.58 Year
- Weight: 4.300 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Cat, Domestic Shorthair, Female, 2 year, 3.039 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Lack of efficacy - NOS, Elevated amylase, Anaemia NOS, Neutropenia, Monocytosis… • Outcome: Euthanized
- Report ID: USA-USFDACVM-2025-US-045743
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 2.00 Year
- Weight: 3.039 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Unassigned
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.